Trial Profile
Phase 1b trial of RAD001 in patients with operable non-small cell lung cancer (NSCLC)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Dec 2006
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Dec 2006 New trial record.